citrate phosphate dextrose has been researched along with 2,3-diphosphoglycerate in 13 studies
*2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508) [MeSH]
*2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508) [MeSH]
| Studies (citrate phosphate dextrose) | Trials (citrate phosphate dextrose) | Recent Studies (post-2010) (citrate phosphate dextrose) | Studies (2,3-diphosphoglycerate) | Trials (2,3-diphosphoglycerate) | Recent Studies (post-2010) (2,3-diphosphoglycerate) |
|---|---|---|---|---|---|
| 146 | 1 | 33 | 1,418 | 39 | 117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandanayingyoung, D; Kiartivich, S; Talalak, P | 1 |
| Koerner, K; Sahlmen, P; Stampe, D | 1 |
| Zauder, HL | 1 |
| Högman, CF | 1 |
| Debrauwere, J; Eriksson, L; Gong, J; Högman, CF; Payrat, JM | 1 |
| Högman, CF; Knutson, F; Lööf, H | 1 |
| Cassidy, GP; Pivacek, LE; Ragno, G; Valeri, CR | 1 |
| Greenwalt, TJ; Hess, JR; Hill, HR; Lippert, LE; Oliver, CK | 1 |
| Högman, CF; Löf, H; Meryman, HT | 1 |
| Ragno, G; Valeri, CR | 1 |
| Cardigan, R; Thomas, S; Wiltshire, M | 1 |
| Back, FP; González, FH; Hlavac, NR; Jane Wardrop, K; Lacerda, LA; Terra, SR | 1 |
| Bozzato, E; Capello, K; Carminato, A; Corrò, M; Crestani, C; Cro, A; Mutinelli, F; Stefani, A; Vascellari, M | 1 |
2 review(s) available for citrate phosphate dextrose and 2,3-diphosphoglycerate
| Article | Year |
|---|---|
Massive transfusion.
Topics: 2,3-Diphosphoglycerate; Acid-Base Imbalance; Animals; Blood Coagulation Disorders; Blood Preservation; Citrates; Diphosphoglyceric Acids; Erythrocyte Aging; Glucose; Humans; Hyperkalemia; Hypocalcemia; Hypothermia; Lung Diseases; Oxygen; Platelet Transfusion; Postoperative Complications; Swine; Transfusion Reaction | 1982 |
Recent advances in the preparation and storage of red cells.
Topics: 2,3-Diphosphoglycerate; Anticoagulants; Blood Platelets; Blood Preservation; Cell Separation; Citrates; Diphosphoglyceric Acids; Erythrocytes; Filtration; Glucose; Humans; Solutions | 1994 |
11 other study(ies) available for citrate phosphate dextrose and 2,3-diphosphoglycerate
| Article | Year |
|---|---|
The effect of rejuvenation on 2, 3-DPG level of preserved red blood cells.
Topics: 2,3-Diphosphoglycerate; Adenine; Adolescent; Adult; Anticoagulants; Blood Preservation; Citrates; Citric Acid; Diphosphoglyceric Acids; Erythrocyte Aging; Erythrocytes; Female; Glucose; Humans; Male; Rejuvenation | 1986 |
In vitro effect on stored red blood cells and platelets after a 15-hour delayed refrigeration of whole blood prior to component preparation in CPD-AD.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Diphosphate; Blood Platelets; Blood Preservation; Cell Survival; Citrates; Cold Temperature; Collagen; Diphosphoglyceric Acids; Erythrocytes; Glucose; Hematocrit; Humans; Hypotonic Solutions; Platelet Aggregation; Serotonin; Time Factors | 1986 |
Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
Topics: 2,3-Diphosphoglycerate; Adenine Nucleotides; Adenosine Triphosphate; Anticoagulants; Blood Preservation; Citrates; Diphosphoglyceric Acids; Erythrocytes; Glucose; Hemolysis; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Osmolar Concentration; Solutions | 1993 |
Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anticoagulants; Blood Glucose; Blood Preservation; Carbon Dioxide; Citrates; Erythrocytes; Glucose; Humans; Hydrogen-Ion Concentration; Lactates; Peroxidase; Temperature; Time Factors | 1999 |
24-hour 51Cr post-transfusion survival, 51Cr life span and haemolysis of red blood cells stored at 4 degrees C for 56 days in AS-3.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Adult; Anticoagulants; Blood Component Removal; Blood Preservation; Cell Separation; Cell Survival; Centrifugation; Chromium Radioisotopes; Citrates; Cryopreservation; Erythrocyte Aging; Erythrocytes; Glucose; Hemoglobins; Hemolysis; Humans; Male; Mannitol; Phlebotomy; Potassium; Sodium Chloride; Time Factors | 2001 |
Alkaline CPD and the preservation of RBC 2,3-DPG.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Blood Preservation; Cell Survival; Citrates; Erythrocytes; Extracellular Space; Glucose; Hemolysis; Humans; Hydrogen-Ion Concentration; Intracellular Fluid; Isotonic Solutions; Osmolar Concentration; Time Factors | 2002 |
Storage of red blood cells with improved maintenance of 2,3-bisphosphoglycerate.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Anticoagulants; Blood Preservation; Citrates; Erythrocytes; Feasibility Studies; Glucose; Hematocrit; Hemolysis; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Time Factors | 2006 |
The effects of preserved red blood cells on the severe adverse events observed in patients infused with hemoglobin based oxygen carriers.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Anemia; Blood Preservation; Blood Substitutes; Blood Transfusion, Autologous; Cell Survival; Chondroitin Sulfates; Citrates; Complex Mixtures; Dextrans; Erythrocytes; Gentamicins; Glucose; Hemoglobins; Hemolysis; Humans; Mannitol; Sodium Chloride; Temperature; Time Factors | 2008 |
Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Adult; Anticoagulants; Blood Preservation; Citrates; Erythrocyte Count; Erythrocytes; Glucose; Humans; Leukocyte Reduction Procedures; Mannitol; Phosphates; Plasma; Refrigeration; Sodium Chloride; Solutions; Time Factors | 2010 |
Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage.
Topics: 2,3-Diphosphoglycerate; Adenine; Adenosine Triphosphate; Animals; Blood Preservation; Cell Survival; Citrates; Dogs; Erythrocytes; Female; Glucose; Hemolysis; Leukocyte Reduction Procedures; Male; Mannitol; Sodium Chloride; Transfusion Reaction | 2014 |
In vitro assessment of quality of citrate-phosphate-dextrose-adenine-1 preserved feline blood collected by a commercial closed system.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Blood Cell Count; Blood Preservation; Blood Specimen Collection; Cats; Citrates; Fibrinogen; Glucose; Hemolysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lactic Acid; Osmotic Fragility; Partial Thromboplastin Time; Potassium; Prothrombin Time | 2018 |